BioSpace News Archive

Kardium is pleased to announce the first clinical use of the Globe Positioning System – the new 3D mapping and navigation feature of its flagship product, the Globe® Mapping and Ablation System.

The University of Texas MD Anderson Cancer Center has named 10 early-career faculty members to the 2020 class of Andrew Sabin Family Fellows.

LIFT-AD clinical trial evaluating ATH-1017, a once-daily investigational drug for the treatment of mild-to-moderate Alzheimer’s disease, actively enrolling

Eton Pharmaceuticals, Inc, a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, reported financial results for the third quarter ended September 30, 2020 and provided an update on business progress.

Verrica Pharmaceuticals Inc., a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced that Ted White, Verrica President and CEO, will present a business overview at the Jefferies Virtual London Healthcare Conference on Tuesday, November 17, 2020, at 2:55 p.m. ET.

Nkarta, Inc., a clinical-stage biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced that the first patient has been treated in the first-in-human Phase 1 clinical trial of NKX101 for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes.

Helius Medical Technologies, Inc., a neurotech company focused on neurological wellness, reported financial results for the quarter ended September 30, 2020.

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class cell and exosome-based therapeutics for the treatment and prevention of a variety of diseases and disorders, announced today its financial results for the third quarter ending September 30, 2020 and provided a corporate update.

In total, the Nomination Committee represents approx. 45 percent of the total number of shares and votes in the company.

TOMI Environmental Solutions, Inc.® announced its results for the third quarter of 2020.